(1191–1220) Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster II

Monday, October 27, 2025

10:30 AM - 12:30 PM Central Time

Location: Hall F1

CE: 0.00

Presentations:

10:30 AM - 12:30 PM Central Time

anti-ro52 Antibody Identifies Patients with More Severe Lung Disease Among Patients with Idiopathic Inflammatory Myopathy
Abstract Poster Presenter: Vasiliki Syrmou, MD, MSc – University General Hospital of Larissa
10:30 AM - 12:30 PM Central Time

Artificial Intelligence-based Capillaroscopy and Laboratory Biomarkers to Predict Disease Activity in Idiopathic Inflammatory Myopathies: Preliminary Data from the Capiami Cohort
Abstract Poster Presenter: Jorge Álvarez-Troncoso, MD, PhD (MD, PhD) – Hospital Universitario La Paz
10:30 AM - 12:30 PM Central Time

Association of paraoxonase1 Activity with Calcinosis in Patients with Scleroderma and Dermatomyositis : An Exploratory Analysis
Abstract Poster Presenter: Sangmee Bae, MD, MS – UCLA
10:30 AM - 12:30 PM Central Time

Beyond Muscle Strength: Functional Performance Measures Enhance Assessment of Disease Activity in Juvenile Dermatomyositis
Abstract Poster Presenter: Jia Shi, MD – University of Washington
10:30 AM - 12:30 PM Central Time

Cutaneous and Muscular Disease Trajectories in Adult Patients with Dermatomyositis
Abstract Poster Presenter: Jesus Valencia, MD – Johns Hopkins Bayview Medical Center
10:30 AM - 12:30 PM Central Time

Discordance between Immunoblot and ELISA in the detection of Jo-1 and Ro/Ro-52 Autoantibodies
Abstract Poster Presenter: Antonia Valenzuela, MD, MS – Pontificia Universidad Catolica de Chile
10:30 AM - 12:30 PM Central Time

Effect of ER Stress Inhibition With 4-Phenylbutyric Acid on Disease Phenotype in a Mouse Model of Myositis
Abstract Poster Presenter: Alfredo Guzman, PhD (he/him/his) – Binghamton University
10:30 AM - 12:30 PM Central Time

Genetic Profiling of Idiopathic Inflammatory Myopathies in Indian Patients Reveals Genotype-Phenotype Correlation
Abstract Poster Presenter: BANDANA JASSAL, MSc (she/her/hers) – ALL INDIA INSTITUTE OF MEDICAL SCIENCES, NEW DELHI
10:30 AM - 12:30 PM Central Time

High Prevalence of Asymptomatic Interstitial Lung Disease in Idiopathic Inflammatory Myopathies: Validation of ACR/CHEST Risk Factors in a Hong Kong Cohort
Abstract Poster Presenter: Iris Tang, MBBS, MRCP – Department of Medicine, LKS Faculty of Medicine, University of Hong Kong
10:30 AM - 12:30 PM Central Time

Idiopathic Inflammatory Myopathies: A Prospective Phase 4 Controlled Trial Of Recombinant Herpes Zoster Vaccine
Abstract Poster Presenter: ANA PAULA LUPPINO-ASSAD, MD, PhD – Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo (HC/FMUSP)
10:30 AM - 12:30 PM Central Time

Induction of stable, GC-free remission in patients with severe, therapy-refractory anti-synthetase syndrome after using the bispecific CD19xCD3 T cell engager blinatumomab
Abstract Poster Presenter: Christina Duesing, MD – Klinik f�r Rheumatologie
10:30 AM - 12:30 PM Central Time

Interstitial Lung Disease in Systemic Autoimmune Rheumatic Diseases (SARDs): Radiologic and Histologic Correlations
Abstract Poster Presenter: Darya S. Jalaledin, MD – Université de Montréal
10:30 AM - 12:30 PM Central Time

Lung Transplant Outcomes in Patients with Myositis- and Systemic Sclerosis-Associated Interstitial Lung Disease Compared to Idiopathic Pulmonary Fibrosis: A Multicentric Retrospective Analysis
Abstract Poster Presenter: Angela Chang, MD – University of British Columbia
10:30 AM - 12:30 PM Central Time

Measurement Properties of a Shorter Health Assessment Questionnaire (HAQ-II) in Patients with Inflammatory Myopathies
Abstract Poster Presenter: Sung-Ki Lee, MD – Rush Medical College
10:30 AM - 12:30 PM Central Time

Mortality in Idiopathic Inflammatory Myopathy in the Toulouse cohort (MIIRTALITY)
Abstract Poster Presenter: Gregory Pugnet, MD,PhD (he/him/his) – CHU Toulouse Rangueil Service de Medecine Interne et Immunologie Clinique
10:30 AM - 12:30 PM Central Time

Neutrophil Activation in Juvenile Dermatomyositis: Associations with Muscle Function and Disease Progression
Abstract Poster Presenter: Jia Shi, MD – University of Washington
10:30 AM - 12:30 PM Central Time

Overexpression of lymphotoxin in autophagy-deficient mice as model for inclusion body myositis
Abstract Poster Presenter: Jens Schmidt, MD – Immanuel University Hospital Rüdersdorf, Brandenburg Medical School; Department of Neurology and Pain Therapy
10:30 AM - 12:30 PM Central Time

Plasma Levels of miR-133a-3p and miR-1-3p as Potential Biomarkers of Muscle Involvement and Initial Treatment Response in Myositis
Abstract Poster Presenter: Kristina Svobodová, MD (she/her/hers) – Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University
10:30 AM - 12:30 PM Central Time

Predictors of Progressive Pulmonary Fibrosis in Idiopathic Inflammatory Myopathies : a Retrospective Study of 502 Cases
Abstract Poster Presenter: Wei Bian, MD – Tianjin Medical University
10:30 AM - 12:30 PM Central Time

Prevalence of and Factors Associated with Chronic Opioid Use among Individuals with Inflammatory Myopathies
Abstract Poster Presenter: Anuya Natu, MBBS – John H Stroger, Jr. Hospital of Cook County
10:30 AM - 12:30 PM Central Time

Prognostic Significance of 1-Year Pulmonary Function Changes in Myositis-Associated Interstitial Lung Disease
Abstract Poster Presenter: Irada Choudhuri, MD – University of Pittsburgh Medical Center
10:30 AM - 12:30 PM Central Time

Real-time MRI for assessment of swallowing impairment in inclusion body myositis and oculopharyngeal muscular dystrophy.
Abstract Poster Presenter: Jens Schmidt, MD – Immanuel University Hospital Rüdersdorf, Brandenburg Medical School; Department of Neurology and Pain Therapy
10:30 AM - 12:30 PM Central Time

Relapse in Idiopathic Inflammatory Myopathies: insights from extended MyoCite and Italian Consortia
Abstract Poster Presenter: Maria Rosa Pellico, MD – ASST Pini-CTO, Clinical Rheumatology Unit
10:30 AM - 12:30 PM Central Time

Remission Rates and Predictors in Idiopathic Inflammatory Myopathy Subtypes: Insights from a Single-Center Cohort
Abstract Poster Presenter: Sidra Tahir, MD, MBBS (she/her/hers) – University of Pittsburgh Medical Center, Mercy
10:30 AM - 12:30 PM Central Time

Risk of Calcinosis with Proton Pump Inhibitor Use in Adult Dermatomyositis and Systemic Sclerosis
Abstract Poster Presenter: Antonia Valenzuela, MD, MS – Pontificia Universidad Catolica de Chile
10:30 AM - 12:30 PM Central Time

Rituximab in Treatment Refractory vs Treatment Naive Anti Signal Recognition Particle (SRP) Myositis A Case Series
Abstract Poster Presenter: ISRARUL HAQUE, MD, MBBS (he/him/his) – Institute of Post graduate Medical Education and Research, Kolkata
10:30 AM - 12:30 PM Central Time

Social Determinants Shape Health Outcomes in Idiopathic Inflammatory Myopathies: Insights from Lived Experience of 1,252 Patients
Abstract Poster Presenter: Tsvetelina Velikova, MD, PhD, MPH (she/her/hers) – Sofia University St. Kliment Ohridski
10:30 AM - 12:30 PM Central Time

Transitional Changes on High Resolution Computed Tomography (HRCT) in idiopathic inflammatory Myopathy- Associated Interstitial Lung Disease (IIM-ILD)
Abstract Poster Presenter: Sangmee Bae, MD, MS – UCLA
10:30 AM - 12:30 PM Central Time

Validation and clincial use of anti-MDA5 test - LIA versus ELISA
Abstract Poster Presenter: TING-YUAN LAN, MD – National Taiwan University Hospital Hsinchu Branch
10:30 AM - 12:30 PM Central Time

Validity and reliability of a new ultrasound-based semiquantitative echogenicity grading scale for myositis.
Abstract Poster Presenter: Jemima Albayda, MD, RhMSUS – Johns Hopkins University